Macromoltek

Revolutionizing antibody design

[Macromoltek @macromoltek]

Macromoltek is celebrating our team this holiday season! Thanks to @vinder_inc and @maizatx for making these personal gift boxes possible.

[Macromoltek @macromoltek]

Join us and @NVIDIAAI at #HLTH2020 conference!
Let's have a conversation about the future of #DrugDiscovery and #MachineLearning

https://t.co/C4bmIyyjVU

[Macromoltek @macromoltek]

Learn about exciting #MachineLearning techniques for #DrugDesign and #DrugDiscovery with Macromoltek!
Join us with @NVIDIAAI at the #HLTH2020 Conference.
Checkout our Blog to learn more! https://t.co/QoEU89rhQe

[Macromoltek @macromoltek]

Thanks @.gordondaugherty for pointing out how our proprietary #computational approach speeds #antibody design. #COVID19 #SARSCoV2

[Gordon Daugherty @gordondaugherty]

@VentureBeat In the meantime, the pharma industry can partner with Austin-based @macromoltek to get faster results than normal. They’re a @CapitalFactory portfolio company.

[Macromoltek @macromoltek]

@monicaberrondo our CEO is delivering her thooughts about what we're doing to stop #COVID19 #Austin #computational #biology

[Renee Yao @ReneeYao1]

#AI-powered #Healthcare Solutions Against #COVID19, brought to you by @lal_avantika, @monicaberrondo, Sahar Arshad, and Sindhu Vijaya-Raghavan, and me next Wed 5/13 8:00am PST. #WIT

Register Now: https://t.co/Kcky3QUWYk

[Macromoltek @macromoltek]

We're honored to be included in the @JohnsHopkins #Whiting School of #Engineering @macromoltek #COVID19 response https://t.co/x4JbFdI9nb #MedTwitter #infectiousdisease #pharma

[Macromoltek @macromoltek]

Thank you @NSFSBIR for recognizing the work @Macromoltek and @CytoviaT is doing to rapidly address the #COVID19 #pandemic We appreciate it!

[Joshua Baer ⚙️ @JoshuaBaer]

.@macromoltek has designed a pool of virtual candidate antibodies to prevent COVID-19. These antibodies may be used as a prophylactic to prevent front-line workers from being infected or to improve outcomes for those already affected. @CFHealthTech

[Macromoltek @macromoltek]

Check out our press release talking about the deployment of our platform to help combat #COVID19

[Macromoltek @macromoltek]

We're quickening the #drug design process #MEDTwitter #Antibodies #pharma #InfectiousDisease

[Macromoltek @macromoltek]

#Computational #biology #hybrid #biotech Thanks @DDNewsOnline

[Macromoltek @macromoltek]

@FrenchMorningNY @FrenchMorningTX

[Macromoltek @macromoltek]

Exciting partnership here with @CytoviaT and yes, very hopeful that our platform will speed #antibody design

[Raminderpal Singh, PhD @raminderpal_]

@Macromoltek deploys #AI #ML #platform through an application with @CytoviaT in fight against #SARSCoV2 #coronavirus #COVID-19. We're hopeful that this partnership will yield positive results. #MedTwitter #infectiousdisease https://t.co/eRVqsLM7R0

[Macromoltek @macromoltek]

Thank you for sharing our news @megha_prn

[Megha Desai @megha_prn]

@Macromoltek deploys #AI #ML #platform through an application with @CytoviaT in fight against #SARSCoV2 #coronavirus #COVID-19. We're hopeful that this partnership will yield positive results. #MedTwitter #infectiousdisease https://t.co/n3oBDv1b46

[Macromoltek @macromoltek]

Thanks @C2Pharma for the follow--interesting portfolio of work #innovation #lifesciences

[Macromoltek @macromoltek]

@SudaPharmaLtd Great work in increasing bioavailability of #drugs #innovation #lifescience

[Macromoltek @macromoltek]

We're revolutionizing antibody design with computational modeling for #COVID19 usa @macromoltek's CEO Monica Berrondo shares in this video about what we're up to #BigPharma #VentureCapital

https://t.co/2jWkL8DQy6

[Macromoltek @macromoltek]

We're proud to be doing our part to stop the COVID-19 pandemic. Thank you @ycombinator for bringing attention to our work.

[Y Combinator @ycombinator]

20+ YC bio and healthcare companies responding to COVID-19, how you can help them, and a new request for startups: https://t.co/kkD47bITVx

[Macromoltek @macromoltek]

You're looking at a nanodisc! This is a mock phospholipid bilayer which mimics the phospholipid bilayer found surrounding most animal cells. What could it be used for? https://t.co/iwShJCOaZ0

[Macromoltek @macromoltek]

A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor (TNF) superfamily. It plays a role in B cell maturation and generation. Unlike other TNF-ligands, APRIL promotes the survival of tumor cells in tissue culture. https://t.co/ostpiO7Px0